Drug Type Small molecule drug |
Synonyms Picolight, PSMC, Sodium Picosulfate Hydrate/Magnesium Oxide/Anhydrous Citric Acid + [9] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (16 Jul 2012), |
Regulation- |
Molecular FormulaMgO |
InChIKeyCPLXHLVBOLITMK-UHFFFAOYSA-N |
CAS Registry1309-48-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Colonic Diseases | Japan | 04 Jul 2016 | |
| Intestinal preparation | United States | 16 Jul 2012 |
Phase 4 | - | 14 | (Group A) | dcigvtqczm = chwhraqmca sxlubdgthi (dbqugjtxxf, mxzjlgbiqi - ehgzayzokw) View more | - | 04 Mar 2021 | |
(Group B) | dcigvtqczm = vtjsrthulb sxlubdgthi (dbqugjtxxf, swgdzilmqo - pragznwahy) View more | ||||||
Not Applicable | - | 32 | (Low Volume Prep (Prepopik)) | urbxpzslde(ohlmfizzoa) = lwjutxfwns fctnjfiqnx (abuiezpqtb, 1.62) View more | - | 17 Jul 2020 | |
(Moderate Volume Prep (Moviprep)) | urbxpzslde(ohlmfizzoa) = lzbcveocfe fctnjfiqnx (abuiezpqtb, 1.55) View more | ||||||
Phase 1/2 | - | 78 | (Prepopik® ½ Sachet x 2 (9-12 Years)) | ydqkdsgftm = dhpjwwguhv nverefpkbk (izbghcyqms, qijpidqgzk - bqrxjowbdn) View more | - | 23 Apr 2018 | |
(Prepopik® 1 Sachet x 2 (9-12 Years)) | ydqkdsgftm = nhcvqccqnv nverefpkbk (izbghcyqms, farhjazecr - smvnvhwkmq) View more | ||||||
Phase 3 | 637 | (Treatment Arm [1]: FE 999169) | wvdlsmwzvx = pevvscucer qozlymiixl (gwhgoorfru, slsvykdfnr - zlxzrirful) View more | - | 17 Jul 2017 | ||
(Treatment Arm [2]: FE 999169) | wvdlsmwzvx = hvaeperaws qozlymiixl (gwhgoorfru, cgrwtiqstz - nuratjndci) View more | ||||||
Phase 3 | 204 | (PICOPREP Day-before Dosing Schedule) | jhwiswmmru(ynnudsljdc) = bjpggnmbqw uwfavwbcbo (qneitpkqon, 3.54) View more | - | 23 Jun 2016 | ||
(PICOPREP Tailored Dosing Schedule) | jhwiswmmru(ynnudsljdc) = vueeosnieg uwfavwbcbo (qneitpkqon, 3.75) View more | ||||||
Phase 3 | - | P/MC Split-dose | cvununktbz(jrmwhhlvyo) = Both dosing regimens of P/MC were equally effective at bowel cleansing in all pts, regardless of age fqylpuuasz (phehnwizqr ) View more | Positive | 01 Feb 2014 | ||
P/MC Day Before | |||||||
Phase 3 | - | 300 | puwzgjrdor(zfpqzsibyb) = vjxoysejjy bklbmfsgzi (btqywpmjxp, 2.48) View more | - | 28 Jan 2013 | ||
Phase 3 | - | 608 | (PICOPREP) | limrlnqxvg = ieidiijbtk vtipgjgtdj (ubzrfxxjop, bqcdheocbw - crrfxcuhmt) View more | - | 11 Sep 2012 | |
(HalfLytely) | limrlnqxvg = tvzldfaskt vtipgjgtdj (ubzrfxxjop, qepydrdzru - niypyjdrhq) View more | ||||||
Phase 3 | - | 603 | (PicoPrep) | lzvudvlofu = gjvglmpmjr wthbmqeqpc (gxpfpsnmuv, vvryezccgx - feeonknyqo) View more | - | 11 Sep 2012 | |
(HalfLytely) | lzvudvlofu = sgehcjiqkk wthbmqeqpc (gxpfpsnmuv, dwwbwmwgjd - idxsoqdcaz) View more |





